University of Würzburg-ko ikertzaileekin lankidetzan egindako argitalpenak (6)

2019

  1. Chimeric antigen receptor T-cell therapy for multiple myeloma: A consensus statement from the European Myeloma Network

    Haematologica, Vol. 104, Núm. 12, pp. 2358-2360

2016

  1. Practical Considerations for the Use of Daratumumab, a Novel CD38 Monoclonal Antibody, in Myeloma

    Drugs, Vol. 76, Núm. 8, pp. 853-867

2014

  1. New drugs and novel mechanisms of action in multiple myeloma in 2013: A report from the International Myeloma Working Group (IMWG)

    Leukemia, Vol. 28, Núm. 3, pp. 525-542

2012

  1. Management of treatment-emergent peripheral neuropathy in multiple myeloma

    Leukemia, Vol. 26, Núm. 4, pp. 595-608

2009

  1. International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders

    Leukemia, Vol. 23, Núm. 2, pp. 215-224

  2. International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100)

    Leukemia, Vol. 23, Núm. 10, pp. 1904-1912